Low-magnitude high-frequency vibration (LMHFV) has been proven to promote osteoporotic fracture healing. Mechanical stimulation was reported to enhance SDF-1/ CXCR4 signalling in mesenchymal stem cells (MSCs). We hypothesised that LMHFV promoted osteoporotic fracture healing by enhancing MSC migration through the SDF-1/ CXCR4 pathway. 152 ovariectomised SD-rats received closed femoral fracture in groups of vibration+MSC (VMG) (20 min/d, 5 d/week), vibration+MSC+AMD3100 (VMAG; AMD, a CXCR4 inhibitor) (1 mg/kg/d, intraperitoneal), MSC (MG) (1 × 10 6 MSC, intracardiac) or control (CG) for a treatment duration of 2, 4 or 8 weeks. MSC migration was evaluated by ex-vivo green fluorescent protein signal in the callus; and fracture healing was examined by weekly radiographs, endpoint computedtomography and mechanical test. At week-2 and week-4, ex-vivo callus GFP intensity of VMG was significantly higher than other groups (p < 0.05). From week-2 to week-3, both callus width and callus area in VMG were significantly larger; and from week-7 to week-8, smaller than other groups (p < 0.05). At week-8, high-density bone volume fraction, bone volume fraction, bone mineral density and stiffness in VMG were significantly higher than other 3 groups (p < 0.05). This study demonstrated that LMHFV promoted MSC migration and fracture healing in osteoporotic rats. This effect was attenuated by CXCR4 inhibitor, providing strong evidence that SDF-1-mediated MSC migration was one of the important mechanisms through which LMHFV enhanced fracture healing.
Introduction
Osteoporotic fracture healing is a growing public health concern due to the ageing global population (Cummings and Melton, 2002) . Millions of fractures still occur annually as a result of traumatic injuries. Although most fractures will successfully heal within a few months, a proportion of fracture cases still result in delayed healing or even nonunion (Claes et al., 2012) which may prolong treatment period and increase morbidity of the patients. Healing of fractures in osteoporotic bone is impaired (Giannoudis et al., 2007) in many ways, including callus formation and remodelling capacities Giannoudis et al., 2007; Shi et al., 2010) , gene expression Chung et al., 2014) , angiogenesis (Sun et al., 2012) , and also systemic recruitment of reparative mesenchymal stem cells (MSCs) (Granero-Molto et al., 2009; Marsell and Einhorn, 2011) . MSCs are the musculoskeletal lineage of multipotent stromal cells capable of differentiating into bone, cartilage, tendon, adipose and muscle cells (Caplan, 1991; Minguell et al., 2001; Short et al., 2003) with high reparative potentials. In case of a fracture, MSCs are recruited to the site of fracture from various tissues and organs (da Silva Meirelles et al., 2006) by the inflammatory cascade (Kolar et al., 2011) . Therefore, MSCs play an important role in the early phase of fracture healing.
Although the fracture healing process has been very well described, the molecular regulation of the event is not completely understood. Amongst the cytokines released that regulate the healing process and the systemic recruitment of MSCs, the stromal cell-derived factor-1 (SDF-1) and its target receptor of chemokine (C-X-C) receptor-4 (CXCR4) are suggested to be highly related (Houthuijzen et al., 2012; Ma et al., 2011; Ponomaryov et al., 2000) . Granero-Molto et al. (2009) found that implanted MSCs were recruited to the fracture site in an exclusively CXCR4-dependent manner; and Kitaori et al. (2009) showed that SDF-1 level was elevated in the periosteum of injured bone, which recruited MSCs homing to the graft bone at the fracture site and promoted endochondral bone formation. Moreover, SDF-1 was found to be highly expressed and involved in MSC trafficking in a novel induced membrane technique used to repair large bone defects (Cuthbert et al., 2013) .
Low-magnitude high-frequency vibration (LMHFV) treatment was reported to be a promising non-pharmaceutical
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intervention with the potential to accelerate fracture healing in both normal and osteoporotic bones Chung et al., 2014; Leung et al., 2009; Shi et al., 2010) . Our research group has previously reported that LMHFV was able to enhance ovariectomy-induced osteoporotic fracture healing through enhancing the endochondral ossification process (Shi et al., 2010) , the callus remodelling process , and also the increase of blood flow, neo-vasculature and the protein expression of vascular endothelial growth factor (VEGF) in fracture callus when compared to non-vibrated controls (Cheung et al., 2012b) . As all of these are important contributing factors and their enhancement are much related to the recruitment of highly reparative MSCs to the fracture site, we hypothesised that the enhancement effect of LMHFV on osteoporotic fracture healing was related to the enhanced systemic recruitment of MSCs, regulated by the SDF-1/CXCR4 signalling pathway.
The objectives of the study were to investigate (i) the effect of LMHFV on the recruitment of MSCs to the fracture site; and (ii) the role of the SDF-1/CXCR4 signalling pathway during the recruitment process.
Materials and Methods

Experimental design
In this study, we employed the well-established closed femoral fracture model in ovariectomy-induced osteoporotic rats. Exogenous green-fluorescent protein (GFP)-labelled MSCs were used to demonstrate the treatment effect of LMHFV in terms of MSC recruitment that could be objectively quantified and detected by a fluorescence imaging system . A CXCR4 antagonist, AMD3100 (Chabannon et al., 2011; Wei et al., 2014) , was used to block the SDF-1/ CXCR4 pathway to reveal the role of this pathway in MSC recruitment during osteoporotic fracture healing augmented with LMHFV. Grouping of the osteoporotic rats is as stated in Table 1 . Sample size for each time-point was n = 10 for green fluorescent protein (GFP) signal and µCT assessments, and n = 8 for the endpoint mechanical test. A total of 152 rats were used for this study. Fracture healing related outcomes are assessed at time-points of 2, 4 and 8 weeks after fracture creation.
Osteoporotic closed femoral fracture model
All animal experimentation procedures were approved by the Animal Experimentation Ethics Committee of the Chinese University of Hong Kong (Ref: CUHK 11/010/ GRF-5). The osteoporotic fracture rat models were created according to our previously described protocol Leung et al., 2009; Wei et al., 2014) . In brief, each rat received bilateral ovariectomy under general anaesthesia at the age of 6 months and aged for 3 additional months for the development of osteoporosis. At the age of 9-months, an intramedullary K-wire (390152A, Stryker, Kalamazoo, MI, USA) was surgically inserted followed by closed femoral fracture creation by a standardised 3-point-bending apparatus. Post-operational X-ray (MX-20, Faxitron Bioptics LLC, Tucson, AZ, USA) was used to confirm a transverse and non-comminuted fracture for each successful case. All animal surgeries were performed by the same researcher to ensure consistency.
Intra-cardiac injection of GFP-labelled MSCs
The procedure was performed according to our previously established protocol . On day 3 postfracture (2 d before vibration treatment), 1.0 × 10 6 GFP-labelled MSCs (SD Rats, RASMX-01101, Cyagen, Guangzhou, China) in 500 µL phosphate-buffered saline (PBS) were transplanted by intracardiac injection as previous described Furlani et al., 2009) . Briefly, the GFP-labelled MSCs were sub-cultured to the fifth passage, and then were trypsinised and diluted in 0.9 % normal saline. A 23G needle was inserted through the thoracic wall at a point left to the sternum on a line connecting the left axillary pivot with the caudal tip of the sternum. The syringe containing the MSC suspension was aspirated followed by the injection of the MSC suspension by gently pressing the piston of the syringe. The position of the needle was confirmed by an ultrasound system (Vevo 770, VisualSonics, Toronto, ON, Canada) under B-mode.
LMHFV treatment
Rats receiving the LMHFV treatment were placed in a custom-made bottomless rat holder directly on the custombuilt vibration platform transmitting vertical vibrations at 35 Hz and a magnitude of 0.3 ×g. Treatment was started on the fifth day after fracture creation and was given 20 min per day, 5 consecutive days (Mon-Fri) per week until the endpoint of the experiment based on our previously reported treatment scheme (Cheung et al., 2012b; Leung et al., 2009; Shi et al., 2010) . Rats were euthanised with an overdose of 20 % pentobarbital at endpoints.
AMD3100 administration
According to previously the published protocol, AMD3100 was dissolved in 0.9 % saline solution to a final concentration of 1 mg/mL for intraperitoneal injection at a dose of 1 mg/kg/d (De Clercq, 2003; Wei et al., 2014) 30 min before LMHFV treatment to the VAMG group. All other groups received equivalent amounts of vehicle injection.
Weekly radiography
Two-dimensional digital radiographs (MX-20, Faxitron, Lincolnshire, IL, USA) were taken weekly post-fracture to confirm the quality and degree of fracture healing. The
Sample size (n) was 10 per group per time-point. Abbreviations: V = vibration, A = AMD3100 injection, M = MSC injection, G = group. (Shi et al., 2010) , where callus width (CW) was defined as the maximal outer diameter of the mineralised callus minus the outer diameter of the femur; and callus area (CA) was calculated as the sum of the areas of the external mineralised callus, assessed independently by three researchers.
Ex-vivo GFP intensity analysis
After euthanasia at the specified endpoints (2, 4 and 8 weeks post-fracture), fracture femora were harvested with soft tissue carefully removed. GFP signals were quantified and fluorescent images were acquired (IVIS 200, Xenogen, Alameda, CA, USA). The fluorescence analysis was calibrated to the standard as recommended by the IVIS imaging operation manual. The intensities (in counts) were measured using the Live Image 2.5 software at an exposure time of 5 s, binning of 8 and f/16 Granero-Molto et al., 2009) . A standard circular region-ofinterest (ROI) with a diameter of 1 cm was defined around the callus area for all measurements. After background noise reduction, the intensities within the ROI were used to evaluate the average intensities, based on our previously established protocol .
µCT analysis
Ex vivo micro-computed tomography scans (μCT40, Scanco Medical, Brüttisellen, Switzerland) were then performed after GFP intensity analysis, based on our established protocol (Cheung et al., 2012a; Leung et al., 2009) . The femora were positioned vertically with normal saline-soaked gauze in the sample holder during scanning. The newly formed bone (low-density bone, threshold = 165-350) and highly mineralised bone (high-density bone, threshold = 350-1000) were reconstructed separately (Fung et al., 2012; Leung et al., 2009) . The ratios of lowdensity bone volume over total tissue volume (BV l /TV), high-density bone volume over total tissue volume (BV h / TV), total bone volume fraction (BV t /TV) and bone mineral density (BMD) were evaluated.
Immunohistochemistry (IHC) of GFP
After completing the µCT scanning, the fractured femora were fixed, decalcified and paraffin embedded. Histological sections were cut at 5 μm thick for observation. Protein expression of GFP was stained by immunohistochemistry using commercially available mouse monoclonal primary antibodies for GFP (ab38689 at dilution of 1:100, Abcam, Cambridge, UK) and rabbit specific colour developing kit (ab80437) with Harris haematoxylin counter-staining as previously reported . Three random sites were selected at the bony callus for image capturing under a 10× objective (Leica DFC495, Leica Microsystems GmbH, Wetzlar, Germany). The stained area was segmented by colour thresholding normalised with negative control, and expressed as percentage (%) area fraction averaged from three separate images for comparison.
Mechanical test
A four-point bending test was performed at week 8 postfracture. A separate batch of 32 rats (n = 8 per group) were euthanised at week 8 post-treatment with the whole femur dissected free from soft tissue. A material testing machine (H25KS Hounsfield Test Equipment Ltd, Redhill, UK) was used to test the femora to failure loaded in the anterior-posterior direction and a constant displacement of 5 mm/min according to established protocol (Cheung et al., 2012a; Shi et al., 2010) . Ultimate load, stiffness and energy to failure were recorded for further analysis.
Statistical analysis
All quantitative data were expressed as mean ± standard deviation (SD) and analysed with SPSS version 20.0 software (IBM, Armonk, NY, USA). One-way analysis of variance (ANOVA) with Tukey's post-hoc test were used for two-group or multiple-group comparisons, respectively. Statistical significance was set at p < 0.05.
Results
Clinical observations
Apparent bone mineral density (BMD) drop in the ovariectomised groups was confirmed in 5 random rats by µCT to be 396.4 ± 57 to 250.6 ± 49 mgHA/ ccm (p = 0.0000287). All fractured rats in all groups returned to normal locomotion within the first week of fracture creation. All rats in control and treatment groups progressed to complete healing with no case of non-union observed. Twelve rats (7.9 %) resulted in comminuted fractures after creation and were immediately euthanised, excluded from the study and later replaced. All rats receiving LMHFV treatment showed signs of relaxation by self-grooming behaviour, but no signs of depression or excessive weight loss.
Weekly radiography
Callus morphometry by X-ray ( Fig. 1 ) expressed in width and area are summarised in Fig. 2 and Fig. 3 . In general, callus width was shown to be significantly higher in the VMG at week 2 (p = 0.001 vs. VAMG group, and p < 0.0005 with both MG and CG groups) and week 3 (p = 0.012 vs. VAMG group, p = 0.017 vs. MG group, and p = 0.019 vs. CG group) as compared to all other groups. The VAMG group showed no significant difference with the CG and MG groups. Callus width decreased more rapidly in the VMG group compared to all other groups at week 7 (p = 0.007 vs. MG group, and p = 0.005 vs. CG group) and week 8 (p = 0.002 vs. MG group, and p = 0.001 vs. CG group) with significant difference. Similar results were observed for the callus area.
Ex-vivo GFP signal intensity
Qualitatively, the signal intensity was highest in the VMG at an early time point of 2 weeks compared to other groups, and the increased signal was not detected in the VAMG group. Blue circle with uniform diameter indicates the ROI
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Fig. 1. Serial X-ray. Representative X-ray images showing the healing process in each group. In general, the VMG group showed earlier bridge at week 3 to week 4 with greater callus size detected at earlier time-points followed by a more rapid decrease in callus size at later time-points. VMG, MG and CG groups showed similar trends throughout the observed period of 8 weeks. 
selected for signal quantification (Fig. 4) . The ex vivo GFP intensity in the VMG was significantly higher than those in the VAMG (p = 4.7 × 10 ) at week 2. No significant difference was detected between MG and CG at week 2 (p = 0.062). No significant difference was detected at week 4 to week 8. (Fig. 5) .
µCT analysis
From the 3D reconstruction images, the callus volume in the VMG group was found to be greatest at week 4 compared to the VAMG, MG and CG groups. It was also found that the decrease in callus size was fastest in the VMG group as compared to all other groups (Fig. 6) . Mean tissue volume (TV) in the VMG was significantly larger than the VAMG (p = 0.006), MG (p < 0.005) and CG (p < 0.005) groups at week 2, and significantly larger than VAMG (p = 0.023) and CG (p = 0.027) at week 4 post-fracture (Fig. 7A) . Mean bone volume (BV) in the VMG group was significantly larger than those in the MG (p = 0.006) and CG (p = 0.031) groups at week 2, and higher compared with the VAMG group (p = 0.001) at week 4 post-fracture (Fig. 7B) . Mean high-density bone volume (BV h ) in VMG was significantly higher than MG (p = 0.028) and CG (p = 0.015) at week 2, and higher than MG (p = 0.044) at week 8 post-fracture (Fig. 7C) . Mean BV h /TV in VMG was significantly higher than VAMG (p < 0.005), MG (p < 0.005) and CG (p < 0.005) at week 8 post-fracture (Fig. 7D) . Mean total bone volume fraction (BV/TV) in the VMG group was significantly higher than the VAMG (p < 0.005), MG (p < 0.005) and CG (p < 0.005) groups at week 8 post-fracture (Fig. 7E) . Mean bone mineral density (BMD) in the VMG group was significantly higher than in the VAMG (p < 0.005), MG (p < 0.005) and CG (p < 0.005) groups at week 8 post-fracture (Fig. 7F ).
GFP immunohistochemistry
GFP was detected at the fracture callus in all groups, with the strongest signals at the intramedullary canal within the remodelling fracture callus and site where endochondral ossification occurred (Fig. 8A-C) . Mean area fraction of GPF by IHC showed a significantly higher signal detected in the VMG group against all other groups at week 2 (p < 0.005), and no significant difference was detected between VAMG and MG groups (p = 0.834). Likewise, a slightly higher signal was detected in the VMG group at week 4 against all other groups (p < 0.05) and no significant difference was detect among all other groups. At week 8, no significant difference was detected between VMG and VAMG groups (Fig. 9) .
Mechanical test
Four-point bending results at 8-week post-fracture indicated that the ultimate load, stiffness and energy to failure were generally higher in the VMG group when compared with other groups. Statistically significant higher stiffness was detected in the VMG group compared with VAMG, MG and CG groups (p = 0.050, p < 0.0005 and p = 0.001, respectively). No significant difference was Fig. 3 . Callus area. Callus area was also found significantly enhanced by both LMHFV treatment along with exogenous MSC injection in the VMG group at week 2 to 4. The enhancement effect was suppressed by AMD3100 as shown in the VAMG group. Sample size of n = 10 per group per time-point with one-way ANOVA adjusted by Tukey's post-hoc test at p < 0.05 considered statistically significant. 
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found between the VAMG, MG and CG groups in all of the mechanical properties tested (Table 2) .
Discussion and Conclusion
This study aims to investigate the effect of LMHFV on MSC recruitment to the diaphyseal fracture site and the role of the SDF-1/CXCR4 signalling pathway, where diaphyseal fracture healing occurs predominately by the process of endochondral ossification. The results in this study reconfirmed the capacity of LMHFV, in combination with transplanted MSCs, to enhance fracture healing in osteoporotic bone Chung et al., 2014; Shi et al., 2010) . In this study, MSC recruitment is the Representative images of whole femur specimens in all groups shown at all timepoints. In general, the signal intensity was highest in the VMG group at an early time point of 2 weeks compared to other groups, and the increased signal was not detected in the VAMG group. Blue circle with uniform diameter indicates the ROI selected for signal quantification. Superscript of (1, 2, 3, 4) represent Bonferroni post-hoc test with significant difference (p < 0.05) compared with VMG, VAMG, MG and CG, respectively 
Ultimate load (N)
Stiffness
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focus and is demonstrated to be enhanced in response to the treatment of LMHFV through the SDF-1/CXCR4 signalling pathway. No fracture non-union has been observed and all fracture models progressed to union at end-point of the study in all groups. In the process of fracture healing, SDF-1 was reported to modulate the homing and engraftment of circulating MSCs by binding to its receptor CXCR4, thus expanding the pool of osteogenic precursor cells in the fracture site . In this study, GFP-labelled MSCs at the fracture site were shown to be enhanced at week 2 post fracture in the VMG group when compared to the MG and CG groups, which confirmed the effectiveness of LMHFV treatment in recruiting MSCs to the fracture site in osteoporotic bone. The VMG, VAMG and MG groups showed a 3.18×, 1.63× and 1.70× increase in ex vivo GFP signals, respectively, when compared to the CG group. Upon the addition of the CXCR4 antagonist (AMD3100), the enhancement effect of LMHFV on the VAMG group immediately dropped from 3.18× to 1.63×; which is also confirmed by immunohistochemistry of GFP at the fracture site to show a consistent trend. This observation indicates the importance that SDF-1/CXCR4 played in recruitment of MSCs to the fracture site in response to LMHFV. LMHFV might have achieved this by increasing the expression and secretion of SDF-1 at the fracture site, as SDF-1 is expressed and secreted by several cell types including osteoblasts, fibroblasts and endothelial cells (Jacobs et al., 2010) . Moreover, a similar in vivo study in mice by Leucht et al. (2013) demonstrated that application of strain would enhance SDF-1 expression in osteoblasts and osteocytes and the expression of CXCR4 in marrow MSCs, and thus concluded the role played by MSCs in mechanoadaptation of bone. Also, the current finding is consistent with our previous report regarding the in vitro up-regulation of SDF-1 and CXCR4 mRNA expression, as well as the release of SDF-1 in the culture medium after treating MSCs with another form of mechanical Fig. 5 . Quantification of GFP signal intensity. MSC recruitment was found to be highest by GFP signal at week 2 to week 4 in the VMG group; and significantly smaller in the VAMG group with no statistical significant difference from the MG group.
www.ecmjournal.org F-Y Wei et al. LMHFV enhanced MSC SDF-1 in osteoporotic fracture
stimulation, low intensity pulsed ultrasound (LIPUS) . Moreover, recent reports have demonstrated similar findings that transplantation with or without overexpression of SDF-1 would both improve fracture healing (Ho et al., 2015; Rapp et al., 2015) . Therefore, much like other forms of mechanical stimulation, LMHFV was shown to be capable of enhancing MSC recruitment to the fracture site; and the SDF-1/CXCR4 signalling pathway was essential during the process. LMHFV treatment was also found to be capable of improving blood circulation and neo-angiogenesis (Cheung et al., 2012b) . In this study, exogenous MSCs were injected directly into the circulation, and treatment of LMHFV was proven capable of increasing blood circulation. Thus, it is not surprising that augmentation in blood circulation and angiogenesis may have played an important role in providing the required vessels for the successful recruitment of circulating MSCs. These two mechanisms may work synergistically during the augmentation by LMHFV, as it was reported by Kasper et al. (2007) that the in vitro mechanical loading of MSC would result in a paracrine stimulation of angiogenesis, possibly through the fibroblast growth factor receptor 1 (FGFR1) signalling pathway or the vascular endothelial growth factor receptor (VEGFR) signalling cascade. In this study, enhanced MSC recruitment was observed at week 2 to week 4 in the LMHFV-treated group, as compared to the observed enhancement in angiogenesis at week 2 to week 8 (Cheung et al., 2012b) at the fracture site. This suggests a relationship between the two mechanisms that may work either independently or synergistically to achieve the enhancement effects, which requires further investigation to answer.
Subsequently, the enhancement effect of MSC recruitment by LMHFV in osteoporotic fracture healing was reflected in callus formation and remodelling parameters. As compared to classical stages of fracture healing (Einhorn, 1998; Schindeler et al., 2008) , after LMHFV treatment was given to osteoporotic fractured bone, callus size generally showed more rapid increase in the soft callus formation stage at early time-points and a more rapid remodelling stage at later time-points. As shown by the callus size and µCT data, the VMG group had significant increase in callus width and area at early time points, increased high-density bone volume fraction at later time points (Fig. 7, week 8) and subsequently accelerating the remodelling process leading to faster healing as shown by the faster decrease in callus volume (Fig. 7) . Ultimately, the enhancement in callus formation and remodelling in the VMG group was manifested by the end-point mechanical properties in stiffness (resistance to deformation) versus all other groups (Table 2 ). Since mechanical stimulation Fig. 6 . µCT reconstruction. Representative 3-dimensional reconstructed images of the fracture callus. In general, the callus volume in the VMG group was found to be greatest at 4 weeks compared to the VAMG, MG and CG groups. It was also found that the decrease in callus size was fastest in the VMG group and compared to all other groups.
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may promote MSCs to differentiate into different cell types, including adipocytes, osteoblasts and chondrocytes, the results of this study suggests that LMHFV treatment might be capable of promoting differentiation of MSCs at the fracture site to osteogenic cell types (Qi et al., 2008) that contribute to the enhanced process of callus formation, callus remodelling and ultimately improved mechanical properties.
Although it was observed that the GFP signal intensity at the fracture site was apparently higher in the injectiononly MG group at week 2 compared to the control CG group without significant difference, there were no significant enhancement in callus morphometry compared to the CG group in other assessed parameters. This indicates that the injection of exogenous MSCs alone did not provide an additional enhancement effect in callus formation in 
osteoporotic fracture by simply increasing the amount of circulating MSCs. This observation is not surprising as our previous empirical results have indicated that enhancement in fracture healing would only occur when injected MSC number reached 4.0 × 10 6 in the same rat fracture model . Moreover, it has been previously reported by Furlani et al. (2009) that the injection of 3.0 × 10 6 exogenous MSCs in mice would not enhance cardiac functions. Our experimental design was intended to introduce a small reporter signal and thus injected only a relatively smaller amount of 1.0 × 10 6 isolated MSCs in the rat models Nagaya et al., 2005; Wei et al., 2014) , thus confirming that MSC recruitment was enhanced by LMHFV.
Mechanical stimulation in the form of LMHFV and LIPUS are both promising in providing adequate stimulatory signals to achieve enhancements in fracture healing. In contrast to the systemic whole body vibration provided by LMHFV, LIPUS belongs to the type of local mechanical stimulation treated directly superficial to the fracture site. In our previous study on rat fracture healing augmented with LIPUS treatment, the ex vivo GFP signal intensity in the LIPUS treatment group also showed significant increase (2.66×) in signal strength compared to the control group . The enhancement in MSC recruitment was translated to comparable enhancement effects in callus formation capacity, at around 26.8 % to 35 % increase in callus size during week 1 to 3 in 8-week old rat fractures. Moreover, upon the addition of the AMD3100 in the modulation group, the enhancement effect of LIPUS showed similar abolishment as shown in this study, indicating that both types of mechanical Fig. 9 . Quantitative immunohistochemistry of GFP at the fracture site. GFP-labelled MSCs were found to be higher in concentration at the fracture site in the VMG group versus the SDF-1/CXCR4 blocked VAMG group. The result is demonstrated by higher positive signals detected in the VMG group at week 2 and 4 versus all groups (p < 0.0005, p = 0.029, respectively) and no difference was detected between VMG and MG groups at week 2 and week 4 (p = 0.834, p = 0.149, respectively).
stimulation achieved the enhancement effects in bone healing through the SDF-1/CXCR4 pathway. Although the effect of AMD3100 on fracture healing might depend on the administration scheme of various doses, time and duration (Toupadakis et al., 2013; Toupadakis et al., 2012) , the present findings are in line with these reports indicating that a sustained blockade of CXCR4 reduced callus formation and maturation. These in vivo studies together convey strong evidence to support the important role of the SDF-1/CXCR4 pathway in the recruitment of MSCs to the fracture site augmented by mechanical stimulation. Moreover, LIPUS also showed an in vitro positive effect on enhancing expression of SDF-1 and CXCR4 in MSCs, suggesting that a similar effect can be achieved by LMHFV.
As it was also shown by another study that the application of low magnitude vibration treatment at 90 Hz would increase the MSC cell population in long bone marrow (Luu et al., 2009) , the effect of LMHFV on the expression of SDF-1 and CXCR4 in MSCs and various cell types needs further investigation to be confirmed. It is demonstrated that exogenously injected MSCs are recruited to the fracture site through the SDF-1/CXCR4 pathway and the blockade of this pathway would suppress the enhancement effect brought about by mechanical stimulation. However, circulating MSCs only represent a small population of reparative MSCs which would normally reside as a majority in bone marrow (da Silva Meirelles et al., 2006; Margulies et al., 2015; Young et al., 1995) . Thus, our model was only able to demonstrate the recruitment of circulating MSCs to the fracture site and assumed that bone marrow MSCs were also recruited to the injury site in close proximity. Another limitation is the lack of an AMD3100-only modulation group in this study design, as this agent was only used as a tool to investigate the role of the SDF-1/CXCR4 signalling pathway in the mechanically stimulated fracture group, and its sole effects on similar models without mechanical stimulation were previously well reported (Leucht et al., 2013; Toupadakis et al., 2013; Toupadakis et al., 2012) . Also, future experiments on the expression of SDF-1/CXCR4 at the fracture site might provide additional insight to reveal the effect of LMHFV on resident MSC recruitment.
In conclusion, all rats in all groups progressed to complete healing. It was found that LMHFV enhanced exogenous injected MSC recruitment in osteoporotic diaphyseal fracture healing that led to enhancement in fracture healing in terms of callus formation, remodelling and improved mechanical properties. It was also shown that SDF-1/CXCR4 was essential for the enhancement effect in MSC recruitment provided by LMHFV. Our results suggest the possible clinical application LMHFV in combination with MSC treatments for osteoporotic fracture healing.
